GHERMAN, A.; CĂINAP, C.; CONSTANTIN, A.-M.; CETEAN, S.; CĂINAP, S. S. Molecular targeted treatment of metastatic colorectal cancer: the cardiovascular adverse effects of Bevacizumab and Cetuximab. Medicine and Pharmacy Reports, [S. l.], v. 90, n. 4, p. 377–384, 2017. DOI: 10.15386/cjmed-745. Disponível em: https://medpharmareports.com/index.php/mpr/article/view/745. Acesso em: 6 oct. 2025.